Advertisement

Topics

Abemaciclib shows positive result in Phase III advanced breast cancer study

06:19 EDT 16 Apr 2018 | SmartBrief

A late-stage study showed that the addition of Eli Lilly and Co.'s abemaciclib to an initial nonsteroidal aromatase inhibitor -More

Original Article: Abemaciclib shows positive result in Phase III advanced breast cancer study

NEXT ARTICLE

More From BioPortfolio on "Abemaciclib shows positive result in Phase III advanced breast cancer study"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...